Prothena Corp. Plc (PRTA)
9.265
-0.16
(-1.65%)
USD |
NASDAQ |
Aug 26, 16:00
9.265
0.00 (0.00%)
After-Hours: 16:17
Prothena Price to Book Value : 1.671 for Aug. 26, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 1.699 |
| August 24, 2026 | 1.694 |
| August 21, 2026 | 1.704 |
| August 20, 2026 | 1.629 |
| August 19, 2026 | 1.676 |
| August 18, 2026 | 1.571 |
| August 17, 2026 | 1.602 |
| August 14, 2026 | 1.598 |
| August 13, 2026 | 1.638 |
| August 12, 2026 | 1.670 |
| August 11, 2026 | 1.663 |
| August 10, 2026 | 1.645 |
| August 07, 2026 | 1.58 |
| August 06, 2026 | 1.548 |
| August 05, 2026 | 1.531 |
| August 04, 2026 | 1.531 |
| August 03, 2026 | 1.502 |
| July 31, 2026 | 1.464 |
| July 30, 2026 | 1.517 |
| July 29, 2026 | 1.544 |
| July 28, 2026 | 1.544 |
| July 27, 2026 | 1.569 |
| July 24, 2026 | 1.578 |
| July 23, 2026 | 1.538 |
| July 22, 2026 | 1.522 |
| Date | Value |
|---|---|
| July 21, 2026 | 1.578 |
| July 20, 2026 | 1.564 |
| July 17, 2026 | 1.562 |
| July 16, 2026 | 1.528 |
| July 15, 2026 | 1.520 |
| July 14, 2026 | 1.558 |
| July 13, 2026 | 1.593 |
| July 10, 2026 | 1.666 |
| July 09, 2026 | 1.739 |
| July 08, 2026 | 1.777 |
| July 07, 2026 | 1.746 |
| July 06, 2026 | 1.713 |
| July 02, 2026 | 1.748 |
| July 01, 2026 | 1.728 |
| June 30, 2026 | 1.766 |
| June 29, 2026 | 1.693 |
| June 26, 2026 | 1.701 |
| June 25, 2026 | 1.574 |
| June 24, 2026 | 1.596 |
| June 23, 2026 | 1.621 |
| June 22, 2026 | 1.554 |
| June 18, 2026 | 1.516 |
| June 17, 2026 | 1.442 |
| June 16, 2026 | 1.408 |
| June 15, 2026 | 1.384 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Alkermes Plc | 4.555 |
| Amarin Corp. Plc | 0.6808 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.36 |
| Anika Therapeutics, Inc. | 2.117 |
Price to Book Value Related Metrics
| PS Ratio | 9.086 |
| Price | 9.265 |
| Earnings Yield | -8.97% |
| Market Cap | 479.41M |